Small fiber neuropathy: A disabling and underrecognized syndrome

Current Opinion in Pulmonary Medicine

Volumn 23, Issue 5, 2017, Pages 447-457

  Voortman, Mareye ^a,b   Fritz, Daan ^c   Vogels, Oscar J M ^a   Eftimov, Filip ^c   Van De Beek, Diederik ^c   Brouwer, Matthijs C ^c   Drent, Marjolein ^a,d  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

autoimmune disorders; autonomic dysfunction; sarcoidosis; small fiber neuropathy

Indexed keywords

AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; CLINICAL FEATURE; CONFOCAL MICROSCOPY; CORNEA; EVOKED RESPONSE; FIBROMYALGIA; GOLD STANDARD; HUMAN; MORBIDITY; MUTATION; NEUROPATHIC PAIN; NOCICEPTIVE PAIN; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW; SCREENING; SENSORY ANALYSIS; SKIN BIOPSY; SKIN TEST; SMALL FIBER NEUROPATHY; SYMPTOM; WRINKLE; DISEASE MANAGEMENT; GENETICS;

SCN9A PROTEIN, HUMAN; SODIUM CHANNEL NAV1.7;

DISEASE MANAGEMENT; HUMANS; NAV1.7 VOLTAGE-GATED SODIUM CHANNEL; SMALL FIBER NEUROPATHY;

EID: 85021065235     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000413     Document Type: Review

References (139)

1. Peters MJ, Bakkers M, Merkies IS, et al. Incidence and prevalence of small-fiber neuropathy: a survey in the Netherlands. Neurology 2013; 81:1356-1360.
2. Lauria G, Lombardi R. Small fiber neuropathy: is skin biopsy the holy grail? Curr Diab Rep 2012; 12:384-392.
3. Themistocleous AC, Ramirez JD, Serra J, Bennett DL. The clinical approach to small fibre neuropathy and painful channelopathy. Pract Neurol 2014; 14:368-379.
4. Lauria G, Morbin M, Lombardi R, et al. Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 2003; 61:631-636.
5. Bednarik J, Vlckova-Moravcova E, Bursova S, et al. Etiology of small-fiber neuropathy. J Peripher Nerv Syst 2009; 14:177-183.
6. De Sousa EA, Hays AP, Chin RL, et al. Characteristics of patients with sensory neuropathy diagnosed with abnormal small nerve fibres on skin biopsy. J Neurol Neurosurg Psychiatry 2006; 77:983-985.
7. Devigili G, Tugnoli V, Penza P, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 2008; 131:1912-1925.
8. Farhad K, Traub R, Ruzhansky KM, Brannagan TH 3rd. Causes ofneuropathy in patients referred as 'idiopathic neuropathy'. Muscle Nerve 2016; 53:856-861.
9. Gemignani F, Giovanelli M, Vitetta F, et al. Nonlength dependent small fiber neuropathy. A prospective case series. J Peripher Nerv Syst 2010; 15:57-62.
10. Khan S, Zhou L. Characterization of nonlength-dependent small-fiber sensory neuropathy. Muscle Nerve 2012; 45:86-91.
11. Loseth S, Stalberg EV, Lindal S, et al. Small and large fiber neuropathy in those with type 1 and type 2 diabetes: a 5-year follow-up study. J Peripher Nerv Syst 2016; 21:15-21.
12. Faber CG, Hoeijmakers JG, Ahn HS, et al. Gain of function Nanu1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 2012; 71:26-39.
13. Faber CG, Lauria G, Merkies IS, et al. Gain-of-function Nav1.8 mutations in painful neuropathy. Proc Natl Acad Sci USA 2012; 109:19444-19449.
14. Hoeijmakers JG, Faber CG, Merkies IS, Waxman SG. Painful peripheral neuropathy and sodium channel mutations. Neurosci Lett 2015; 596:51-59.
15. Samuelsson K, Kostulas K, Vrethem M, et al. Idiopathic small fiber neuro-pathy: phenotype, etiologies, and the search for Fabry disease. J Clin Neurol 2014; 10:108-118.
16. Biegstraaten M, Hollak CE, Bakkers M, et al. Small fiber neuropathy in Fabry disease. Mol Genet Metab 2012; 106:135-141.
17. Uceyler N, Kahn AK, Kramer D, et al. Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control study. BMC Neurol 2013; 13:47.
18. McManis PG, Windebank AJ, Kiziltan M. Neuropathy associated with hy-perlipidemia. Neurology 1994; 44:2185-2186.
19. Ng Wing Tin S, Plante-Bordeneuve V, Salhi H, et al. Characterization of pain in familial amyloid polyneuropathy. J Pain 2015; 16:1106-1114.
20. Gondim Fde A, Araujo DF, Oliveira IS, Vale OC. Small fiber dysfunction in patients with Wilson's disease. Arq Neuropsiquiatr 2014; 72:592-595.
21. Sturniolo GC, Lazzarini D, Bartolo O, et al. Small fiber peripheral neuropathy in Wilson disease: an in vivo documentation by corneal confocal microscopy. Invest Ophthalmol Vis Sci 2015; 56:1390-1395.
22. Kamerman PR, Moss PJ, Weber J, et al. Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models. J Peripher Nerv Syst 2012; 17:19-31.
23. Mangus LM, Dorsey JL, Laast VA, et al. Unraveling the pathogenesis of HIV peripheral neuropathy: insights from a simian immunodeficiency virus macaque model. ILAR J 2014; 54:296-303.
24. Polydefkis M, Yiannoutsos CT, Cohen BA, et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 2002; 58:115-119.
25. Mellion ML, Silbermann E, Gilchrist JM, et al. Small-fiber degeneration in alcohol-related peripheral neuropathy. Alcohol Clin Exp Res 2014; 38:1965-1972.
26. Nguyen TP, Bangert C, Biliciler S, et al. Dermatomyositis-associated sensory neuropathy: a unifying pathogenic hypothesis. J Clin Neuromuscul Dis 2014; 16:7-11.
27. Sene D, Cacoub P, Authier FJ, et al. Sjogren syndrome-associated small fiber neuropathy: characterization from a prospective series of 40 cases. Medicine (Baltimore) 2013; 92:e10-e18.
28. Chin RL, Latov N. Peripheral neuropathy celiac disease. Curr Treat Options Neurol 2005; 7:43-48.
29. Bakkers M, Merkies IS, Lauria G, et al. Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology 2009; 73:1142-1148.
30. Hoitsma E, Marziniak M, Faber CG, et al. Small fibre neuropathy in sarcoi-dosis. Lancet 2002; 359:2085-2086.
31. Caro XJ, Winter EF. Evidence of abnormal epidermal nerve fiber density in fibromyalgia: clinical and immunologic implications. Arthritis Rheumatol 2014; 66:1945-1954.
32. Kosmidis ML, Koutsogeorgopoulou L, Alexopoulos H, et al. Reduction of intraepidermal nerve fiber density (IENFD) in the skin biopsies of patients with fibromyalgia: a controlled study. J Neurol Sci 2014; 347:143-147.
33. Sturm D, Schmidt-Wilcke T, Greiner T, et al. Confocal cornea microscopy detects involvement of corneal nerve fibers in a patient with light-chain amyloid neuropathy caused by multiple myeloma: a case report. Case Rep Neurol 2016; 8:134-139.
34. Martinez V, Fletcher D, Martin F, et al. Small fibre impairment predicts neuropathic pain in Guillain-Barre syndrome. Pain 2010; 151:53-60.
35. Schneider C, Bucher F, Cursiefen C, et al. Corneal confocal microscopy detects small fiber damage in chronic inflammatory demyelinating polyneuro-pathy (CIDP). J Peripher Nerv Syst 2014; 19:322-327.
36. Kass-Iliyya L, Javed S, Gosal D, et al. Small fiber neuropathy in Parkinson's disease: a clinical, pathological and corneal confocal microscopy study. Parkinsonism Relat Disord 2015; 21:1454-1460.
37. Podgorny PJ, Suchowersky O, Romanchuk KG, Feasby TE. Evidence for small fiber neuropathy in early Parkinson's disease. Parkinsonism Relat Disord 2016; 28:94-99.
38. Dalla Bella E, Lombardi R, Porretta-Serapiglia C, et al. Amyotrophic lateral sclerosis causes small fiber pathology. Eur J Neurol 2016; 23:416-420.
39. Weis J, Katona I, Muller-Newen G, et al. Small-fiber neuropathy in patients with ALS. Neurology 2011; 76:2024-2029.
40. Cazzato D, Castori M, Lombardi R, et al. Small fiber neuropathy is a common feature of Ehlers-Danlos syndromes. Neurology 2016; 87:155-159.
41. Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther 2008; 120:1-34.
42. Zeng L, Alongkronrusmee D, van Rijn RM. An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US. J Pain Res 2017; 10:219-228.
43. Uceyler N, Kafke W, Riediger N, et al. Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology 2010; 74:1806-1813.
44. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 1992; 107:660-664.
45. Ferreira SH, Lorenzetti BB, Bristow AF, Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 1988; 334:698-700.
46. Hoitsma E, Faber CG, van Santen-Hoeufft M, et al. Improvement of small fiber neuropathy in a sarcoidosis patient after treatment with infliximab. Sarcoi-dosis Vasc Diffuse Lung Dis 2006; 23:73-77.
47. Putzu GA, Figarella-Branger D, Bouvier-Labit C, et al. Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain-Barre syndrome. J Neurol Sci 2000; 174:16-21.
48. Khoshnoodi MA, Truelove S, Burakgazi A, et al. Longitudinal assessment of small fiber neuropathy: evidence of a non-length-dependent distal axono-pathy. JAMA Neurol 2016; 73:684-690.
49. Brenaut E, Marcorelles P, Genestet S, et al. Pruritus: an underrecognized symptom of small-fiber neuropathies. J Am Acad Dermatol 2015; 72:328-332.
50. Hovaguimian A, Gibbons CH. Diagnosis and treatment of pain in small-fiber neuropathy. Curr Pain Headache Rep 2011; 15:193-200.
51. Civelek GM, Ciftkaya PO, Karatas M. Evaluation of restless legs syndrome in fibromyalgia syndrome: an analysis of quality of sleep and life. J Back Musculoskelet Rehabil 2014; 27:537-544.
52. Oaklander AL, Herzog ZD, Downs HM, Klein MM. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 2013; 154:2310-2316.
53. Ewing DJ, Boland O, Neilson JM, et al. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia 1991; 34:182-185.
54. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007; 115:387-397.
55. Bakkers M, Faber CG, Hoeijmakers JG, et al. Small fibers, large impact: quality of life in small-fiber neuropathy. Muscle Nerve 2014; 49:329-336.
56. Uceyler N, Zeller D, Kahn AK, et al. Small fibre pathology in patients with fibromyalgia syndrome. Brain 2013; 136:1857-1867.
57. Blackmore D, Siddiqi ZA. Diagnostic criteria for small fiber neuropathy. J Clin Neuromuscul Dis 2017; 18:125-131.
58. Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33:2285-2293.
59. Datema M, Gert van Dijk J, Hoitsma E. The diagnostic value of water immersion skin wrinkling and neuropads in small fiber neuropathy. Clin Neurophysiol 2012; 123:2074-2079.
60. Ping Ng KW, Ong JJ, Nyein Nyein TD, et al. EMLA-induced skin wrinkling for the detection of diabetic neuropathy. Front Neurol 2013; 4:126.
61. Teoh HL, Chow A, Wilder-Smith EP. Skin wrinkling for diagnosing small fibre neuropathy: comparison with epidermal nerve density and sympathetic skin response. J Neurol Neurosurg Psychiatry 2008; 79:835-837.
62. Wilder-Smith EP, Guo Y, Chow A. Stimulated skin wrinkling for predicting intraepidermal nerve fibre density. Clin Neurophysiol 2009; 120:953-958.
63. Bakkers M, Faber CG, Reulen JP, et al. Optimizing temperature threshold testing in small-fiber neuropathy. Muscle Nerve 2015; 51:870-876.
64. Hoitsma E, Drent M, Verstraete E, et al. Abnormal warm and cold sensation thresholds suggestive of small-fibre neuropathy in sarcoidosis. Clin Neuro-physiol 2003; 114:2326-2333.
65. Magda P, Latov N, Renard MV, Sander HW. Quantitative sensory testing: high sensitivity in small fiber neuropathy with normal NCS/EMG. J Peripher Nerv Syst 2002; 7:225-228.
66. Periquet MI, Novak V, Collins MP, et al. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 1999; 53:1641-1647.
67. Scott K, Simmons Z, Kothari MJ. A comparison of quantitative sensory testing with skin biopsy in small fiber neuropathy. J Clin Neuromuscul Dis 2003; 4:129-132.
68. Katsarava Z, Yaldizli O, Voulkoudis C, et al. Pain related potentials by electrical stimulation of skin for detection of small-fiber neuropathy in HIV. J Neurol 2006; 253:1581-1584.
69. Lefaucheur JP, Wahab A, Plante-Bordeneuve V, et al. Diagnosis of small fiber neuropathy: a comparative study of five neurophysiological tests. Neurophysiol Clin 2015; 45:445-455.
70. Mueller D, Obermann M, Koeppen S, et al. Electrically evoked nociceptive potentials for early detection of diabetic small-fiber neuropathy. Eur J Neurol 2010; 17:834-841.
71. Parson HK, Nguyen VT, Orciga MA, et al. Contact heat-evoked potential stimulation for the evaluation of small nerve fiber function. Diabetes Technol Ther 2013; 15:150-157.
72. Rage M, Van Acker N, Knaapen MW, et al. Asymptomatic small fiber neuropathy in diabetes mellitus: investigations with intraepidermal nerve fiber density, quantitative sensory testing and laser-evoked potentials. J Neurol 2011; 258:1852-1864.
73. Wu SW, Wang YC, Hsieh PC, et al. Biomarkers of neuropathic pain in skin nerve degeneration neuropathy: contact heat-evoked potentials as a physiological signature. Pain 2017; 158:516-525.
74. Koskinen M, Hietaharju A, Kylaniemi M, et al. A quantitative method for the assessment of intraepidermal nerve fibers in small-fiber neuropathy. J Neurol 2005; 252:789-794.
75. Lauria G, Hsieh ST, Johansson O, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010; 17:903-912; e944-e909.
76. Chen X, Graham J, Dabbah MA, et al. Small nerve fiber quantification in the diagnosis of diabetic sensorimotor polyneuropathy: comparing corneal confocal microscopy with intraepidermal nerve fiber density. Diabetes Care 2015; 38:1138-1144.
77. Dahan A, Dunne A, Swartjes M, et al. ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density. Mol Med 2013; 19:334-345.
78. Quattrini C, Tavakoli M, Kallinikos P, et al. Comparing skin biopsy with corneal confocal microscopy: diagnostic yield of nerve fiber density. Diabetologia 2010; 53:A1114.
79. Tavakoli M, Quattrini C, Abbott C, et al. Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care 2010; 33:1792-1797.
80. Hoitsma E, Faber CG, van Kroonenburgh MJ, et al. Association of small fiber neuropathy with cardiac sympathetic dysfunction in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22:43-50.
81. Low PA, Tomalia VA, Park KJ. Autonomic function tests: some clinical applications. J Clin Neurol 2013; 9:1-8.
82. Novak V, Freimer ML, Kissel JT, et al. Autonomic impairment in painful neuropathy. Neurology 2001; 56:861-868.
83. Casellini CM, Parson HK, Richardson MS, et al. Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. Diabetes Technol Ther 2013; 15:948-953.
84. Selvarajah D, Cash T, Davies J, et al. SUDOSCAN: a simple, rapid, and objective method with potential for screening for diabetic peripheral neuropathy. PLoS One 2015; 10:e0138224.
85. Hoitsma E, De Vries J, Drent M. The small fiber neuropathy screening list: construction and cross-validation in sarcoidosis. Respir Med 2011; 105:95-100.
86. Wilder-Smith EP. Stimulated skin wrinkling as an indicator of limb sympathetic function. Clin Neurophysiol 2015; 126:10-16.
87. Mainka T, Maier C, Enax-Krumova EK. Neuropathic pain assessment: update on laboratory diagnostic tools. Curr Opin Anaesthesiol 2015; 28:537-545.
88. Truini A, Biasiotta A, Di Stefano G, et al. Does the epidermal nerve fibre density measured by skin biopsy in patients with peripheral neuropathies correlate with neuropathic pain? Pain 2014; 155:828-832.
89. Gibbons CH, Griffin JW, Polydefkis M, et al. The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy. Neurology 2006; 66:256-258.
90. Jiang MS, Yuan Y, Gu ZX, Zhuang SL. Corneal confocal microscopy for assessment of diabetic peripheral neuropathy: a meta-analysis. Br J Ophthalmol 2016; 100:9-14.
91. Tavakoli M, Marshall A, Pitceathly R, et al. Corneal confocal microscopy: a novel means to detect nerve fibre damage in idiopathic small fibre neuropathy. Exp Neurol 2010; 223:245-250.
92. Stettner M, Hinrichs L, Guthoff R, et al. Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy. Ann Clin Transl Neurol 2016; 3:88-100.
93. Pop-Busui R, Evans GW, Gerstein HC, et al. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 2010; 33:1578-1584.
94. Sahuc P, Chiche L, Dussol B, et al. Sudoscan as a noninvasive tool to assess sudomotor dysfunction in patients with Fabry disease: results from a case-control study. Ther Clin Risk Manag 2016; 12:135-138.
95. Yajnik CS, Kantikar V, Pande A, et al. Screening of cardiovascular autonomic neuropathy in patients with diabetes using noninvasive quick and simple assessment of sudomotor function. Diabetes Metab 2013; 39:126-131.
96. Hoeijmakers JG, Faber CG, Lauria G, et al. Small-fibre neuropathies-advances in diagnosis, pathophysiology and management. Nat Rev Neurol 2012; 8:369-379.
97. Hoitsma E, Reulen JP, de Baets M, et al. Small fiber neuropathy: a common and important clinical disorder. J Neurol Sci 2004; 227:119-130.
98. Imai E, Kaminaga T, Takada K, et al. Radioactive defect on I-123 MIBG myocardial SPECT imaging in a patient with cardiac sarcoidosis. Clin Nucl Med 2002; 27:729-730.
99. Jamali HK, Waqar F, Gerson MC. Cardiac autonomic innervation. J Nucl Cardiol 2016. [Epub ahead of print]
100. Misumi I, Kimura Y, Hokamura Y, et al. Scintigraphic detection of regional disruption of the adrenergic nervous system in sarcoid heart disease. Jpn Circ J 1996; 60:774-778.
101. Nagamachi S, Jinnouchi S, Nakahara H, et al. 123I-MIBG myocardial scintigraphy in diabetic patients: relationship to autonomic neuropathy. Nucl Med Commun 1996; 17:621-632.
102. Sisson JC, Shapiro B, Meyers L, et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987; 28:1625-1636.
103. van Kroonenburgh M, Mostard R, Voo S. Metaiodobenzylguanidine scinti-graphy in pulmonary and cardiac disease. Curr Opin Pulm Med 2010; 16:511-515.
104. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015; 14:162-173.
105. Ho TW, Backonja M, Ma J, et al. Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies. Pain 2009; 141:19-24.
106. Moore RA, Derry S, Aldington D, et al. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev 2015; CD008242.
107. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17:1113-e88.
108. Moore RA, Straube S, Wiffen PJ, et al. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 2009; CD007076.
109. Moore RA, Wiffen PJ, Derry S, et al. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2014; CD007938.
110. Wiffen PJ, Derry S, Lunn MP, Moore RA. Topiramate for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2013; CD008314.
111. Wiffen PJ, Derry S, Moore RA. Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev 2011; CD006044.
112. Wiffen PJ, Derry S, Moore RA, McQuay HJ. Carbamazepine for acute and chronic pain in adults. Cochrane Database Syst Rev 2011; CD005451.
113. Sommer C, Cruccu G. Topical treatment of peripheral neuropathic pain: applying the evidence. J Pain Symptom Manage 2017; 53:614-629.
114. Bauchy F, Mouraux A, Deumens R, et al. Feasibility of topical applications of natural high-concentration capsaicinoid solutions in patients with peripheral neuropathic pain: a retrospective analysis. Pain Res Manag 2016; 2016:9703036.
115. Estanislao L, Carter K, McArthur J, et al. A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy. J Acquir Immune Defic Syndr 2004; 37:1584-1586.
116. Kieburtz K, Simpson D, Yiannoutsos C, et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team. Neurology 1998; 51:1682-1688.
117. Shlay JC, Chaloner K, Max MB, et al. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. JAMA 1998; 280:1590-1595.
118. Simpson DM, Schifitto G, Clifford DB, et al. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology 2010; 74:413-420.
119. Hammack JE, Michalak JC, Loprinzi CL, et al. Phase III evaluation of nortripty-line for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain 2002; 98:195-203.
120. Kautio AL, Haanpaa M, Saarto T, Kalso E. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J Pain Symptom Manage 2008; 35:31-39.
121. Rao RD, Michalak JC, Sloan JA, et al. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 2007; 110:2110-2118.
122. Kizawa M, Mori K, Iijima M, et al. Intravenous immunoglobulin treatment in painful sensory neuropathy without sensory ataxia associated with Sjogren's syndrome. J Neurol Neurosurg Psychiatry 2006; 77:967-969.
123. Molina JA, Benito-Leon J, Bermejo F, et al. Intravenous immunoglobulin therapy in sensory neuropathy associated with Sjogren's syndrome. J Neurol Neurosurg Psychiatry 1996; 60:699.
124. Morozumi S, Kawagashira Y, Iijima M, et al. Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjogren's syndrome. J Neurol Sci 2009; 279:57-61.
125. Parambil JG, Tavee JO, Zhou L, et al. Efficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis. Respir Med 2011; 105:101-105.
126. Souayah N, Chin RL, Brannagan TH, et al. Effect of intravenous immunoglo-bulin on cerebellar ataxia and neuropathic pain associated with celiac disease. Eur J Neurol 2008; 15:1300-1303.
127. Wakasugi D, Kato T, Gono T, et al. Extreme efficacy of intravenous immu-noglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren's syndrome. Mod Rheumatol 2009; 19:437-440.
128. Wijnen PA, Cremers JP, Nelemans PJ, et al. Association of the TNF-alpha G-308A polymorphism with TNF-inhibitor response in sarcoidosis. Eur Respir J 2014; 43:1730-1739.
129. Tavee JO, Karwa K, Ahmed Z, et al. Sarcoidosis-associated small fiber neuropathy in a large cohort: clinical aspects and response to IVIG and anti-TNF alpha treatment. Respir Med 2017; 126:135-138.
130. Heij L, Niesters M, Swartjes M, et al. Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study. Mol Med 2012; 18:1430-1436.
131. Culver DA, Dahan A, Bajorunas D, et al. Cibinetide improves corneal nerve fiber abundance in patients with sarcoidosis-associated small nerve fiber loss and neuropathic pain. Invest Ophthalmol Vis Sci 2017; 58:BIO52-BIO60.
132. Gerson MC, Craft LL, McGuire N, et al. Carvedilol improves left ventri-cular function in heart failure patients with idiopathic dilated cardiomyo-pathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine. J Nucl Cardiol 2002; 9:608-615.
133. Smulders NM, Bast A, van Kroonenburgh MJ, Drent M. Improvement of cardiac sympathetic nerve function in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25:140-142.
134. Jankovic J, Gilden JL, Hiner BC, et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med 1993; 95:38-48.
135. Wright RA, Kaufmann HC, Perera R, et al. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 1998; 51:120-124.
136. Biaggioni I, Freeman R, Mathias CJ, et al. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension 2015; 65:101-107.
137. Kaufmann H, Freeman R, Biaggioni I, et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology 2014; 83:328-335.
138. Vinik AI, Erbas T, Casellini CM. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. J Diabetes Investig 2013; 4:4-18.
139. Casanova-Molla J, Grau-Junyent JM, Morales M, Valls-Sole J. On the relationship between nociceptive evoked potentials and intraepidermal nerve fiber density in painful sensory polyneuropathies. Pain 2011; 152:410-418.